Skip to main content
. 2026 Aug 10;26:736. doi: 10.1186/s12886-026-05182-0

Table 13.

Longitudinal changes in AGR, the revised ocular inflammatory activity score, and logMAR BCVA according to treatment response

Variable Group Baseline 14 d 6 weeks 3 months P for time effect P for group effect P for interaction
AGR Good treatment response n = 148 1.36 ± 0.25 1.42 ± 0.24 1.48 ± 0.23 1.54 ± 0.22 < 0.001 < 0.001 0.002
AGR Poor treatment response n = 52 1.15 ± 0.22 1.18 ± 0.21 1.21 ± 0.23 1.24 ± 0.24 < 0.001 < 0.001 0.002
Revised ocular inflammatory activity score, 0–12 Good treatment response n = 148 5.05 ± 1.38 3.24 ± 1.80 1.97 ± 1.35 1.08 ± 0.95 < 0.001 < 0.001 0.188
Revised ocular inflammatory activity score, 0–12 Poor treatment response n = 52 7.04 ± 1.15 5.44 ± 2.14 4.48 ± 2.07 3.75 ± 1.78 < 0.001 < 0.001 0.188
logMAR BCVA Good treatment response n = 148 0.46 ± 0.25 0.38 ± 0.22 0.29 ± 0.19 0.21 ± 0.16 < 0.001 < 0.001 0.004
logMAR BCVA Poor treatment response n = 52 0.76 ± 0.34 0.70 ± 0.31 0.64 ± 0.30 0.58 ± 0.28 < 0.001 < 0.001 0.004

Note: Data are presented as mean±standard deviation. The revised ocular inflammatory activity score was calculated as the sum of the anterior chamber cell score, vitreous haze score, OCT activity score, and FFA leakage score, yielding a total score of 0–12. At baseline and 3 months, the revised score was calculated directly from the four component scores. Because the component-level scores were not separately retained at 14 days and 6 weeks in the current working dataset, the values at these two time points were reconstructed by removing the contemporaneous visual impairment component from the original five-domain score and constraining the resulting score to the prespecified range of 0–12. Longitudinal changes were assessed using linear mixed-effects models including treatment-response group, follow-up time, and their interaction as fixed effects, with a patient-specific random intercept. AGR, albumin-to-globulin ratio; BCVA, best-corrected visual acuity; logMAR, logarithm of the minimum angle of resolution; OCT, optical coherence tomography; FFA, fundus fluorescein angiography